Feebris's Product Videos
Feebris's Products & Differentiation
See Feebris's products and how their products differentiate from alternatives and competitors
The core of our AI-powered platform is the proprietary AI-guided examination & triage engine, which translates data from off-the-shelf point-of-care sensors into reliable and actionable clinical insights. The platform has three major components: Mobile App: connects wirelessly to medical sensors (e.g. pulse oximeters, digital stethoscopes) and guides a non-clinical user through AI algorithms for quality control, symptom extraction, and deterioration triage. Clinical Web Portal: clinical teams review, prioritize, and distribute deterioration response, accelerating treatment access. Population Health Management Web Portal: population health teams review insights informing resource allocation and risk management.
When was Feebris founded?
Feebris was founded in 2017.
Where is Feebris's headquarters?
Feebris's headquarters is located at Accelerator London, London.
What is Feebris's latest funding round?
Feebris's latest funding round is Incubator/Accelerator - III.
How much did Feebris raise?
Feebris raised a total of $80K.
Who are the investors of Feebris?
Investors of Feebris include NHS Innovation Accelerator, Digital Health London, Social Starts, TechForce19, 24Haymarket and 5 more.
Who are Feebris's competitors?
Competitors of Feebris include Current Health and 3 more.
What products does Feebris offer?
Feebris's products include Feebris.
Who are Feebris's customers?
Customers of Feebris include Northumbria Foundation Trust and North East London CCG.
You May Also Like
Myia provides a platform for optimizing virtual healthcare delivery through Remote Patient Monitoring, predictive analytics, process control, and workflow orchestration. The platform ingests a wide range of real-world data from curated sensors and sources, transforming it through applied machine intelligence into objective clinical insights. Harnessing the power of human data, Myia equips clinicians with the precise information they need to both optimize care and prevent unplanned events.
Sensome develops micro-sensor technology for smart medical devices. Sensome's sensing technology can be integrated with any medical device to reliably identify biological tissues in contact with the device. The technology combines micrometric impedance sensors that communicate wirelessly outside the body and machine learning algorithms for accurate and predictive real-time analysis.
Glooko's universal diabetes software products provide insights to improve outcomes for people with diabetes and their care teams. Glooko's systems synchronize data from more than 190 diabetes devices and activity trackers, and they deliver integrated, timely and useful patient data, including glucose levels, blood pressure, weight, and food, insulin and medication intake.
Intelligent Implants is developing electrotherapeutic devices to treat disease and aid recovery in bone and other tissues. The company uses data, engineering, and biologics to bring new, active and connected medical devices to healthcare. These integrated devices facilitate treatment for the patient, as well as, decision making for the healthcare professional.
Ultromics is a global health technology company that provides autonomous echocardiography analysis through AI solutions – empowering physicians to make fast, accurate decisions when diagnosing cardiovascular disease. Its cloud-based service, EchoGo, uses artificial intelligence to fully automate the pathway to diagnosis, providing near-instant reports for clinicians without any need for physical software on site.
EarLens provides hearing aids, which use light and a small lens placed on the user's eardrum to directly activate their natural hearing system. It was founded in 2005 and is based in Menlo Park, California.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.